A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes-Reference-Cited by-同舟云学术

A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes

Published:2012-12-15 Issue:5 Volume:22 Page:557-561
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Nomizu Tadashi,Matsuzaki Masami,Katagata Naoto,Kobayashi Yusuke,Sakuma Takeshi,Monma Tomoyuki,Saito Motonobu,Watanabe Fumiaki,Midorikawa Shinichi,Yamaguchi Yoshiko

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12282-012-0432-4.pdf

Reference26 articles.

1. Miki Y, Swensen J, Shattuck-Eidens D, Futrea PA, Harshman K, Tavigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.

2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789–92.

3. Nomizu T, Tsuchiya A, Kanno M, Katagata N, Watanabe F, Yamaki Y, et al. Clinicopathological features of hereditary breast cancer. Breast Cancer. 1997;4:239–42.

4. Nomizu T, Abe R, Tsuchiya A, Utsunomiya J, Watanabe F, Yamaki Y. A clinical study of familial cancer in Japan. In: Weber W, editor. Familial cancer control. European School of Oncology Monographs. Berlin: Springer; 1992. p. 105–11.

5. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480–90.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients;Cancers;2024-07-15

2. Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants;Breast Cancer Research and Treatment;2024-06-20

3. Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients;Breast Cancer Research and Treatment;2024-05-30

4. S1-Leitlinie: Tumorgenetik – Diagnostik im Kontext maligner Erkrankungen;Medizinische Genetik;2022-04-01

5. Concurrent pathogenic variations in patients with hereditary cancer syndromes;European Journal of Medical Genetics;2021-12